147 related articles for article (PubMed ID: 14993029)
21. Photodynamic therapy effectively palliates gynecologic malignancies.
Godoy H; Vaddadi P; Cooper M; Frederick PJ; Odunsi K; Lele S
Eur J Gynaecol Oncol; 2013; 34(4):300-2. PubMed ID: 24020133
[TBL] [Abstract][Full Text] [Related]
22. Continuous low-irradiance photodynamic therapy: a new therapeutic paradigm.
Rogers GS
J Natl Compr Canc Netw; 2012 Oct; 10 Suppl 2():S14-7. PubMed ID: 23055207
[TBL] [Abstract][Full Text] [Related]
23. Survival after photodynamic therapy to non-pulmonary metastatic endobronchial tumors.
McCaughan JS
Lasers Surg Med; 1999; 24(3):194-201. PubMed ID: 10229150
[TBL] [Abstract][Full Text] [Related]
24. Photofrin-mediated photodynamic therapy induces vascular occlusion and apoptosis in a human sarcoma xenograft model.
Engbrecht BW; Menon C; Kachur AV; Hahn SM; Fraker DL
Cancer Res; 1999 Sep; 59(17):4334-42. PubMed ID: 10485481
[TBL] [Abstract][Full Text] [Related]
25. Interstitial photodynamic therapy in the canine prostate.
Lee LK; Whitehurst C; Chen Q; Pantelides ML; Hetzel FW; Moore JV
Br J Urol; 1997 Dec; 80(6):898-902. PubMed ID: 9439405
[TBL] [Abstract][Full Text] [Related]
26. Photodynamic therapy using porfimer sodium as an alternative to cystectomy in patients with refractory transitional cell carcinoma in situ of the bladder. Bladder Photofrin Study Group.
Nseyo UO; Shumaker B; Klein EA; Sutherland K
J Urol; 1998 Jul; 160(1):39-44. PubMed ID: 9628601
[TBL] [Abstract][Full Text] [Related]
27. Photodynamic therapy for anal cancer.
Allison RR; Sheng C; Cuenca R; Bagnato VS; Austerlitz C; Sibata CH
Photodiagnosis Photodyn Ther; 2010 Jun; 7(2):115-9. PubMed ID: 20510306
[TBL] [Abstract][Full Text] [Related]
28. Photodynamic therapy of colorectal cancer using a new light source: from in vitro studies to a patient treatment.
Kashtan H; Haddad R; Yossiphov Y; Bar-On S; Skornick Y
Dis Colon Rectum; 1996 Apr; 39(4):379-83. PubMed ID: 8878495
[TBL] [Abstract][Full Text] [Related]
29. A prospective phase II study on photodynamic therapy with photofrin II for centrally located early-stage lung cancer. The Japan Lung Cancer Photodynamic Therapy Study Group.
Furuse K; Fukuoka M; Kato H; Horai T; Kubota K; Kodama N; Kusunoki Y; Takifuji N; Okunaka T; Konaka C
J Clin Oncol; 1993 Oct; 11(10):1852-7. PubMed ID: 8410109
[TBL] [Abstract][Full Text] [Related]
30. Long-term survival of patients treated with photodynamic therapy for carcinoma in situ and early non-small-cell lung carcinoma.
Corti L; Toniolo L; Boso C; Colaut F; Fiore D; Muzzio PC; Koukourakis MI; Mazzarotto R; Pignataro M; Loreggian L; Sotti G
Lasers Surg Med; 2007 Jun; 39(5):394-402. PubMed ID: 17565719
[TBL] [Abstract][Full Text] [Related]
31. Photodynamic therapy for palliation of locally recurrent breast carcinoma.
Schuh M; Nseyo UO; Potter WR; Dao TL; Dougherty TJ
J Clin Oncol; 1987 Nov; 5(11):1766-70. PubMed ID: 2445930
[TBL] [Abstract][Full Text] [Related]
32. Photodynamic therapy using Photofrin and excimer dye laser treatment for superficial oral squamous cell carcinomas with long-term follow up.
Toratani S; Tani R; Kanda T; Koizumi K; Yoshioka Y; Okamoto T
Photodiagnosis Photodyn Ther; 2016 Jun; 14():104-10. PubMed ID: 26747657
[TBL] [Abstract][Full Text] [Related]
33. Clinical photodynamic therapy for superficial cancer in the oesophagus and the bronchi: 514 nm compared with 630 nm light irradiation after sensitization with Photofrin II.
Grosjean P; Wagnieres G; Fontolliet C; van den Bergh H; Monnier P
Br J Cancer; 1998 Jun; 77(11):1989-95. PubMed ID: 9667680
[TBL] [Abstract][Full Text] [Related]
34. Variable light-dose effect on photodynamic therapy for laryngeal papillomas.
Abramson AL; Shikowitz MJ; Mullooly VM; Steinberg BM; Hyman RB
Arch Otolaryngol Head Neck Surg; 1994 Aug; 120(8):852-5. PubMed ID: 8049048
[TBL] [Abstract][Full Text] [Related]
35. Photodynamic therapy as salvage treatment for local failure after chemoradiotherapy in patients with esophageal squamous cell carcinoma: a phase II study.
Yano T; Muto M; Minashi K; Iwasaki J; Kojima T; Fuse N; Doi T; Kaneko K; Ohtsu A
Int J Cancer; 2012 Sep; 131(5):1228-34. PubMed ID: 22024814
[TBL] [Abstract][Full Text] [Related]
36. Photofrin photodynamic therapy for treatment of AIDS-related cutaneous Kaposi's sarcoma.
Bernstein ZP; Wilson BD; Oseroff AR; Jones CM; Dozier SE; Brooks JS; Cheney R; Foulke L; Mang TS; Bellnier DA; Dougherty TJ
AIDS; 1999 Sep; 13(13):1697-704. PubMed ID: 10509571
[TBL] [Abstract][Full Text] [Related]
37. Preliminary report of photodynamic therapy for intraperitoneal sarcomatosis.
Bauer TW; Hahn SM; Spitz FR; Kachur A; Glatstein E; Fraker DL
Ann Surg Oncol; 2001 Apr; 8(3):254-9. PubMed ID: 11314943
[TBL] [Abstract][Full Text] [Related]
38. Tumor blood-flow changes following protoporphyrin IX-based photodynamic therapy in mice and humans.
Herman MA; Fromm D; Kessel D
J Photochem Photobiol B; 1999; 52(1-3):99-104. PubMed ID: 10643075
[TBL] [Abstract][Full Text] [Related]
39. Anti-tumor effect of PDT using Photofrin in a mouse angiosarcoma model.
Jin I; Yuji M; Yoshinori N; Makoto K; Mikio M
Arch Dermatol Res; 2008 Apr; 300(4):161-6. PubMed ID: 18080130
[TBL] [Abstract][Full Text] [Related]
40. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate.
Henderson BW; Busch TM; Vaughan LA; Frawley NP; Babich D; Sosa TA; Zollo JD; Dee AS; Cooper MT; Bellnier DA; Greco WR; Oseroff AR
Cancer Res; 2000 Feb; 60(3):525-9. PubMed ID: 10676629
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
